CSPC Pharmaceutical Group Ltd CVG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 36.16
- Price/Sales
- 4.30
- Dividend Yield (Trailing)
- 0.99%
- Dividend Yield (Forward)
- 0.17%
- Total Yield
- 0.99%
Company Profile
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Value
- Total Number of Employees
- 23,500
- Website
- https://www.cspc.com.hk
Competitors
Valuation
|
Metric
|
CVG
|
01177
|
01801
|
|---|---|---|---|
Price/Earnings (Normalized) | 36.16 | 18.85 | — |
Price/Book Value | 5.30 | 1.61 | 4.78 |
Price/Sales | 4.30 | 1.85 | 8.21 |
Price/Cash Flow | 24.93 | 8.04 | — |
Price/Earnings
CVG
01177
01801
Financial Strength
|
Metric
|
CVG
|
01177
|
01801
|
|---|---|---|---|
Quick Ratio | 2.32 | 0.90 | 2.59 |
Current Ratio | 2.63 | 1.05 | 3.00 |
Interest Coverage | 276.31 | 11.55 | −15.20 |
Quick Ratio
CVG
01177
01801
Profitability
|
Metric
|
CVG
|
01177
|
01801
|
|---|---|---|---|
Return on Assets (Normalized) | 14.29% | 4.02% | −2.75% |
Return on Equity (Normalized) | 19.78% | 8.61% | −5.12% |
Return on Invested Capital (Normalized) | 17.91% | 5.53% | −5.63% |
Return on Assets
CVG
01177
01801
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Ldzdldhmv | Kkh | $767.4 Bil | |
JNJ
| Johnson & Johnson | Cvsxjgjl | Rdv | $353.7 Bil | |
MRK
| Merck & Co Inc | Ltbtrgkz | Dvb | $319.4 Bil | |
ABBV
| AbbVie Inc | Lmnrfhp | Qjrs | $277.3 Bil | |
AZN
| AstraZeneca PLC ADR | Hgxkwshkk | Dtl | $242.7 Bil | |
NVS
| Novartis AG ADR | Qgbcfrqhy | Gwlh | $205.3 Bil | |
RHHBY
| Roche Holding AG ADR | Gxjhgjflfz | Kjjz | $203.3 Bil | |
AMGN
| Amgen Inc | Bhxvfsdc | Gdzhz | $164.1 Bil | |
PFE
| Pfizer Inc | Jqlztklvp | Ghwql | $160.4 Bil | |
SNY
| Sanofi SA ADR | Vvqxlnjk | Vxt | $121.8 Bil |